Léa Nadège Bonkian

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · The Lancet Infectious Diseases · 2015 · 90 citations

Pharmacy, Infectious Diseases, Pharmacology +12

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

Moussa Lingani, Léa Nadège Bonkian, Isidore Yerbanga et al. · Malaria Journal · 2020 · 37 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change

Halidou Tinto, Léa Nadège Bonkian, Louis Arnaud Nana et al. · Malaria Journal · 2014 · 33 citations · Full text

Medicine, Pharmacology, Antimicrobial Pharmacology +16

Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · Malaria Journal · 2017 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

<i>In Vivo</i> Antiplasmodial Activity of Two Sahelian Plant Extracts on <i>Plasmodium berghei</i> ANKA Infected NMRI Mice

Léa Nadège Bonkian, Rakiswendé Serge Yerbanga, Benjamin K. Koama et al. · Evidence-based Complementary and Alternative Medicine · 2018 · 10 citations · Full text

Life Sciences, Botany, Pharmacology +16